VivaChek's VivaDiag Glycosylated Hemoglobin Test Kit Receives IVDR Certification
Update: 2024-02-20VivaChek is proud to announce that its VivaDiag Glycosylated Hemoglobin Test Kit has received certification under the In Vitro Diagnostic Regulation (IVDR). This certification, granted in February 2024, underscores our commitment to delivering accurate and reliable diagnostic tools for healthcare professionals.
The VivaDiag Glycosylated Hemoglobin Test Kit is designed for the quantitative measurement of glycated hemoglobin (%HbA1c) in human venous whole blood samples. It is intended to monitor long-term glycemic control in individuals previously diagnosed with diabetes mellitus. This innovative in-vitro diagnostic system utilize fluorescence immunoassay technology to provide precise and consistent results, enabling healthcare professionals to make informed decisions about patient care.
The IVDR certification is a testament to our dedication to meeting the highest standards of quality and safety in the development of our diagnostic products. We are proud to offer a comprehensive range of solutions that empower healthcare professionals to deliver the best possible care to their patients.
For more information about the VivaDiag Glycosylated Hemoglobin Test Kit and our other innovative diagnostic solutions, please visit our website or contact us directly.